Cargando…

Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature

INTRODUCTION: In the last years, many new drugs have been developed targeting different oncology pathways, overall improving both quality of life and survival in several malignancies. However, the increase of those therapies is associated with novel toxicities, mainly immune-related adverse events (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demichelis, Chiara, Balestra, Andrea, Lapucci, Caterina, Zuppa, Angela, Grisanti, Stefano G, Prada, Valeria, Pesce, Giampaola, Grasso, Ilaria, Queirolo, Paola, Schenone, Angelo, Benedetti, Luana, Grandis, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955989/ https://www.ncbi.nlm.nih.gov/pubmed/32783159 http://dx.doi.org/10.1007/s10072-020-04604-1

Ejemplares similares

People with Charcot-Marie-Tooth disease and COVID-19: Impaired physical conditions due to the lockdown. An International cross-sectional survey
por: Prada, Valeria, et al.
Publicado: (2020)

Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis
por: Scarsi, Elena, et al.
Publicado: (2023)

High-dose immunoglobulin pulse therapy and risk of Covid19 infection
por: Prada, Valeria, et al.
Publicado: (2020)

Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT
por: Prada, Valeria, et al.
Publicado: (2021)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Neurological long-COVID in the outpatient clinic: Two subtypes, two courses
por: Grisanti, Stefano Giuseppe, et al.
Publicado: (2022)

Neurological complications of COVID-19: A monocentric experience of a neurological outpatient clinic
por: Grisanti, Stefano, et al.
Publicado: (2021)

Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021;88:105196
por: Cabona, Corrado, et al.
Publicado: (2021)

Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
por: Massa, Federico, et al.
Publicado: (2022)

COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
por: Garnero, Martina, et al.
Publicado: (2020)

Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017
por: Prada, Valeria, et al.
Publicado: (2019)

Patients With Suspected Severe Adverse Reactions to COVID-19 Vaccination Admitted to Intensive Care Unit: A Case Report
por: Battaglini, Denise, et al.
Publicado: (2022)

Covid-19 related ataxia and myoclonus: Para- or post-infectious disorder?
por: Grazzini, Matteo, et al.
Publicado: (2021)

Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems
por: Cinquanta, Luigi, et al.
Publicado: (2021)

Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study
por: Prada, Valeria, et al.
Publicado: (2018)

Case Report: Post-COVID-19 Vaccine Recurrence of Guillain–Barré Syndrome Following an Antecedent Parainfectious COVID-19–Related GBS
por: Bellucci, Margherita, et al.
Publicado: (2022)

Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years
por: Gemelli, Chiara, et al.
Publicado: (2022)

The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
por: Saverino, Daniele, et al.
Publicado: (2010)

Tailoring B cell depletion therapy in MS according to memory B cell monitoring
por: Novi, Giovanni, et al.
Publicado: (2020)

How to define and enhance diagnostic and assistance pathways in neuromuscular diseases during the COVID-19 pandemic: the concept of network
por: Astrea, Guja, et al.
Publicado: (2021)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

Acute Cerebellar Ataxia and Myoclonus in SARS‐CoV‐2–Related Encephalopathy Responsive to Immunotherapy: A Case Series
por: Grazzini, Matteo, et al.
Publicado: (2022)

COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series
por: Germano, Francesco, et al.
Publicado: (2022)

Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
por: Boutros, A., et al.
Publicado: (2023)

Quality of life and upper limb disability in Charcot-Marie-Tooth disease: A pilot study
por: Mori, Laura, et al.
Publicado: (2022)

Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase
por: Mauri, Eleonora, et al.
Publicado: (2020)

The primary role of radiological imaging in the diagnosis of rare musculoskeletal diseases. Emphasis on ultrasound
por: Rossi, Federica, et al.
Publicado: (2019)

Parsonage–Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2021)

A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism
por: Veneri, Francesca A, et al.
Publicado: (2022)

Accuracy of receptor-based methods for detection of thyrotropin-receptor autoantibodies: a new automated third-generation immunoassay shows higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism
por: Tozzoli, Renato, et al.
Publicado: (2010)

Neuromuscular transmission monitoring: Beyond the electric shocks and the shaking hands
por: Abdulatif, Mohamed
Publicado: (2013)

The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
por: Bachiller, Sara, et al.
Publicado: (2020)

Beyond the current knowledge on sarcopenia: new insight on neuromuscular factors
por: Venturelli, Massimo, et al.
Publicado: (2022)

An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia
por: Gemelli, Chiara, et al.
Publicado: (2021)

Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases
por: Simone, Rita, et al.
Publicado: (2013)

How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors
por: Jordan, B., et al.
Publicado: (2021)

Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!
por: Rota, Eugenia, et al.
Publicado: (2020)

The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
por: Simone, Rita, et al.
Publicado: (2014)

Iodoprophylaxis and thyroid autoimmunity: an update
por: Teti, Claudia, et al.
Publicado: (2021)

Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3aohnrlno163rjlo4hfeagnrcr